Clinical Trials · NCT04702516
The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
- Phase
- Phase 1/Phase 2
- Recruitment status
- Unknown
- Sponsor
- Morten Frost
- Enrollment
- 64
- Start date
- Mar 2021
- Locations
- 1 site, Denmark
- Primary endpoint
- Procollagen type 1 N-terminal propeptide (P1NP)